Striking the Right Balance in Heart Failure

4583830419_9879ba9f38_z“Recent clinical trials found that, compared with an angiotensin-converting enzyme inhibitor, angiotensin-receptor blocker and neprilysin inhibitor combination therapy decreased cardiovascular mortality in patients with heart failure with reduced ejection fraction. The authors discuss the importance of these findings.”

Leave a Reply

Your email address will not be published. Required fields are marked *